News

Novo Nordisk’s Wegovy gets accelerated US approval for liver disease MASH

Wegovy is the first GLP-1 treatment approved for MASH. Read more at straitstimes.com. Read more at straitstimes.com.
Daijiworld25m

FDA approves Novo Nordisk’s Wegovy for serious liver disease, beating Eli Lilly

Novo Nordisk A/S’s weight-loss drug Wegovy has received FDA approval to treat a serious form of liver disease, giving the ...